期刊文献+

不同性激素结合球蛋白水平对多囊卵巢综合征患者的影响 被引量:28

Clinical features of patients with polycystic ovary syndrome with different SHBG levels
下载PDF
导出
摘要 目的:探索性激素结合球蛋白(SHBG)在多囊卵巢综合征(PCOS)中的作用。方法:比较低水平SHBG组(115例PCOS患者)、正常水平SHBG组(195例PCOS患者)和对照组(95例)之间临床生化各项指标的差异。结果:(1)低水平SHBG组胰岛素抵抗(IR)、代谢综合征(MS)发生率显著高于正常水平SHBG组和对照组(P<0.05);(2)低水平SHBG组DHEAS明显高于正常水平SHBG组(P<0.05);(3)低水平SHBG组FINS、HOMA-IR、TG、TC/HDL、TG/HDL、LDL/HDL明显高于正常水平SHBG组和对照组,其HDL明显低于正常水平SHBG组(P<0.05);(4)相关性分析显示SHBG与HDL呈正相关,与FPG、FINS、HOMA-IR、TG、TC/HDL、TG/HDL、LDL/HDL呈负相关。结论 :低水平SHBG状态下,PCOS患者具有较高的DHEAS,并易发生MS、IR及血脂紊乱。 Objective To investigate the role of SHBG in PCOS. Methods Three hundred and ten PCOS patients were divided into the low-SHBG group , the normal-SHBG group , and 95 healthy women were enrolled in the healthy control group. Results (1) In the low SHBG group, the incidences of IR and MS were higher than those in the the normal SHBG group and the healthy control group (P 〈 0.05); (2) In the low SHBG group, DHEAS was significantly higher than that in the normal SHBG group (P 〈 0.05); (3) In the low SHBG group, FINS, HOMA-IR, TG, TC/HDL, TG/HDL, LDL/HDL were significantly higher than those in the normal SHBG group and the healthy control group , but HDL was significantly lower than that in the normal SHBG group (P 〈 0.05); (4) SHBG was positively correlated with HDL, but was negatively correlated with FPG, FINS, HOMA-IR, TG, TC/HDL, TG/HDL, LDL/HDL. Conclusions Uner the low SHBG level, PCOS patients have high levels of DHEAS, and SHBG may be a risk factor for MS, IR and dislipidemia.
出处 《实用医学杂志》 CAS 北大核心 2016年第12期1969-1971,共3页 The Journal of Practical Medicine
基金 国家中医药管理局国家中医临床研究基地业务建设科研专项课题(编号:JDZX2012039) 国家中医药管理局全国名老中医药专家传承工作室建设项目
关键词 多囊卵巢综合征 性激素结合球蛋白 胰岛素抵抗 Polycystic ovarian syndrome Sex hormone-binding globulin Insulin resistance
  • 相关文献

参考文献4

二级参考文献26

  • 1周武,王薇薇,张文辉,陈丽玲.多囊卵巢综合征患者性激素结合球蛋白和硫酸脱氢表雄酮的相关性分析[J].中国实验诊断学,2007,11(6):763-764. 被引量:16
  • 2Alberti KCMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1 : diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 1998,15 : 539-553.
  • 3Meigs JB, Wilson P WF, Nathan DM, et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham offspring Studies. Diabetes, 2003, 8:2160-2167.
  • 4Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care,2003, 26:575 581.
  • 5Abbasi F, Reaven GM. Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans. Metab, 2002, 51:235-237.
  • 6Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985, 28: 412-419.
  • 7Goodarzi MO, Dumesic DA, Chazenbalk G, et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis [ J ]. Nat Rev En- docrinol, 2011, 7(4): 219-231.
  • 8Acien P, Quereda F, Matallin P, et al. Insulin, androgens, and o- besity in women with and without polycystic ovary syndrome: a het- erogeneous group of disorders [ J ]. Fertil Steril, 1999, 72 ( 1 ) : 32 - 40.
  • 9Ehrmann DA. Polycystic ovary syndrome [ J ]. N Engl J Med, 2005, 352(12) : 1223 -1236.
  • 10Lo JC, Feigenbaum SL, Yang J, et al. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome [ J]. J Clin Endocrinol Metab, 2006, 91 (4) : 1357 -1363.

共引文献152

同被引文献277

引证文献28

二级引证文献284

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部